Neutralization of hemolytic and mouse lethal activities of C. perfringens alpha-toxin need simultaneous blockade of two epitopes by monoclonal antibodies

Microbial Pathogenesis

Volumn 23, Issue 1, 1997, Pages 1-10

  Schoepe, Heike ^a   Wieler, Lothar H ^b   Bauerfeind, Rolf ^b   Schlapp, Tobias ^b   Potschka, Heidrun ^b   Hehnen, Hans Robert ^b   Baljer, Georg ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b NONE

Author keywords

Alpha toxin; Lethal activity; MAbs; Protection; Recombinant alpha toxin fragment

Indexed keywords

ALPHA TOXIN; EPITOPE; NEUTRALIZING ANTIBODY; PHOSPHOLIPASE;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BACTERIAL IMMUNITY; CLOSTRIDIUM PERFRINGENS; HEMOLYSIS; LD 50; LETHALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; RABBIT; TOXIN ANALYSIS;

ANIMALIA; BACILLUS CEREUS; BACTERIA (MICROORGANISMS); CLOSTRIDIUM BIFERMENTANS; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM SORDELLII; ESCHERICHIA COLI; MURINAE; ORYCTOLAGUS CUNICULUS;

EID: 0030842018     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1996.0123     Document Type: Article

References (32)

1. McDonel J.L. Clostridium perfringens. Pharmac Ther. 10:1980;617-655.
2. McDonel J.L. Toxins ofClostridium perfringens. Pharmacology of Bacterial Toxins. 1986;477-517.
3. Smith J.W.G., Smith G. Topley and Wilson's Principles of Bacteriology, Virology, and Immunity. 1984.
4. Yamakawa Y., Ohsaka A. Purification and some properties of phospholipase C (alpha-toxin) ofClostridium perfringens. Biochem J. 81:1977;844-902.
5. MacFarlane M.G., Knight BCJG. The Biochemistry of Bacterial Toxins. I. Lecithinase Activity ofC. welchii. Biochem J. 35:1941;884-902.
6. Willis A.T. Anaerobic Bacteriology Clinical and Laboratory Practice. London: Butterworth. 1977.
7. Taguchi R., Ikezawa H. Studies on the mode of action of phospholipases on mammalian erythrocytes. Ohsaka A, Hayahi K, Sauai Y, Eds.Animal, Plant and Microbial Toxins. 1976;429-436.
8. Mihancea N., Bittner J., Toascen E., Ceacuruanu A., Teodorescu G. Influence de la toxineClostridium perfringens. Arch Roum. 1970.
9. Möllby R. Bacterial phospholipases. Jeljaszewicz J, Waldström T, Eds.Bacterial Toxins and Cell Membranes. 1978;367-424.
10. Boethius J., Rydquist B., Möllby R., Waldström T. Effect of a highly purified phospholipase C on some electrophysiological properties on the frog muscle fiber membrane. Life Sci. 13:1973;171-176.
11. Ohsaka A., Tsuchiya M., Oshio C. Aggregation of platelets in the mesenteric microcirculation of the rat induced alpha-toxin (phospholipases C) ofClostridium perfringens. Toxicol. 16:1978;333-341.
12. Sugahara T., Takahashi T., Yamaya S., Ohsaka A. In vitroClostridium perfringens. Jap J Med Sci Biol. 29:1976;255-263.
13. Leslie D., Fairweather N., Pickard D., Dougan G. Kehoe M. Phospholipase C and hemolytic activities ofClostridium perfringens E. coliBacillus cereus. Mol Microbiol. 3:1989;383-392.
14. Smith L.D. The Pathogenic Anaerobic Bacteria. Springfield, IL: Charles C Thomas. 1975.
15. Tagushi R., Ikezawa H. Studies on the hemolytic and hydrolytic actions of phospholipases C against mammalian erythrocyte membranes. Arch Biochem Biophys. 173:1976;538-545.
16. Sakurai J., Fujii Y., Torii K., Kobayashi K. Dissociation of various biological activities ofClostridium perfringens. Toxicol. 27:1989;317-323.
17. Sato H., Chiba J., Sato Y. Monoclonal antibodies against alpha-toxin ofClostridium perfringens. FEMS Microbiol Lett. 59:1989;173-176.
18. Logan A.J., Williamson E.D., Titball R.W. Epitope mapping of the alpha-toxin ofClostridium perfringens. Infect Immun. 59:1991;4338-4342.
19. Shuttleworth, AD, Percival, DA, Titball, RW, Epitope mapping of Clostridium perfringens, Fehrenbach et al. Bacterial Protein Toxins.
20. Titball R.W., Leslie D.L., Harvey S., Kelly D. Hemolytic and sphingomyelinase activities ofClostridium perfringens. Infect Immun. 59:1991;1872-1874.
21. Sabban E., Laster Y., Loyter A. Resolution of the hemolytic and the hydrolytic activities of phospholipases C preparation from C. perfringens. Eur J Biochem. 28:1972;373-380.
22. Williamson E.D., Titball R.W. A genetically engineered vaccine against alpha-toxin ofClostridium perfringens. Vaccine. 11:1993;1253-1258.
23. Fujii Y., Nomura S., Oshita Y., Sakurai J. Excitatory effect ofClostridium perfringens. Br J Pharmac. 88:1986;531-539.
24. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning. 2nd edn, New York: Cold Spring Habor Laboratory Press. 1989.
25. Sanger F., Nicklen S., Coulson Ch P. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 74:1977;5464-5467.
26. Köhler G., Howe S.C., Milstein C. Fusion between immunoglobulins secreting and nonsecreting myeloma cell-linea. Eur J Immunol. 1976;286-2902.
27. Würzner R., Götze O. Improved ELISA for the analysis of the epitope specificity of monoclonal antibodies. Immunobiol. 175:1987;349.
28. Strockbine N.A., Marques L.R.M., Holmes R.K., O'Brien A.D. Characterization of monoclonal antibodies against Shiga-like Toxin fromEscherichia coli. Infect Immun. 50:1985;349.
29. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 224:1970;680-685.
30. Towbin H., Stachlin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamid gels to nitrocellulose sheets: procedure and some applications. Proc Nat Acad Sci. 76:1979;4350-4354.
31. Rigby G.J. An egg-yolk agar diffusion assay for monitoring of phospholipase C in cultures ofClostridum welchii. J Appl Bacteriol. 50:1981;11-19.
32. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am J Hygiene. 27:1938;493-497.